Literature DB >> 11533716

Monogenic causes of X-linked mental retardation.

J Chelly1, J L Mandel.   

Abstract

Mutations in X-linked genes are likely to account for the observation that more males than females are affected by mental retardation. Causative mutations have recently been identified in both syndromic X-linked mental retardation (XLMR) and in the genetically heterogeneous 'nonspecific' forms of XLMR, for which cognitive impairment is the only defining clinical feature. Proteins that function in chromatin remodelling are affected in three important syndromic forms of XLMR. In nonspecific forms of the disorder, defects have been found in signal-transduction pathways that are believed to function during neuronal maturation. These findings provide important insights into the molecular and cellular defects that underlie mental retardation.

Entities:  

Mesh:

Year:  2001        PMID: 11533716     DOI: 10.1038/35088558

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  58 in total

1.  X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28.

Authors:  Kimberly A Hahn; Gajja S Salomons; Darci Tackels-Horne; Tim C Wood; Harold A Taylor; Richard J Schroer; Herbert A Lubs; Cornelis Jakobs; Rick L Olson; Kenton R Holden; Roger E Stevenson; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

2.  Detecting polymorphisms and mutations in candidate genes.

Authors:  Julianne S Collins; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2002-11       Impact factor: 11.025

3.  Comparative frequency of fragile-X (FMR1) and creatine transporter (SLC6A8) mutations in X-linked mental retardation.

Authors:  J L Mandel
Journal:  Am J Hum Genet       Date:  2004-10       Impact factor: 11.025

4.  Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans.

Authors:  Ye Wu; Amy C Arai; Gavin Rumbaugh; Anand K Srivastava; Gillian Turner; Takashi Hayashi; Erika Suzuki; Yuwu Jiang; Lilei Zhang; Jayson Rodriguez; Jackie Boyle; Patrick Tarpey; F Lucy Raymond; Joke Nevelsteen; Guy Froyen; Mike Stratton; Andy Futreal; Jozef Gecz; Roger Stevenson; Charles E Schwartz; David Valle; Richard L Huganir; Tao Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

5.  AGTR2 in brain development and function.

Authors:  Virginie S Vervoort; Greagory Guzauskas; John Archie; Charles E Schwartz; Roger E Stevenson; Anand K Srivastava
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

Review 6.  Rho-linked genes and neurological disorders.

Authors:  Nael Nadif Kasri; Linda Van Aelst
Journal:  Pflugers Arch       Date:  2007-11-15       Impact factor: 3.657

Review 7.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

8.  Modulation of dendritic spines and synaptic function by Rac1: a possible link to Fragile X syndrome pathology.

Authors:  Odelia Y N Bongmba; Luis A Martinez; Mary E Elhardt; Karlis Butler; Maria V Tejada-Simon
Journal:  Brain Res       Date:  2011-05-17       Impact factor: 3.252

9.  ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory.

Authors:  Matthew Grove; Galina Demyanenko; Asier Echarri; Patricia A Zipfel; Marisol E Quiroz; Ramona M Rodriguiz; Martin Playford; Shelby A Martensen; Matthew R Robinson; William C Wetsel; Patricia F Maness; Ann Marie Pendergast
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  A new chromosome x exon-specific microarray platform for screening of patients with X-linked disorders.

Authors:  Stavros Bashiardes; Ludmila Kousoulidou; Hans van Bokhoven; Hans-Hilger Ropers; Jamel Chelly; Claude Moraine; Arjan P M de Brouwer; Hilde Van Esch; Guy Froyen; Philippos C Patsalis
Journal:  J Mol Diagn       Date:  2009-09-24       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.